GREEN PLANET MICROCAPS
ESG MICROCAP SPECIALISTS
Our treasure chest is filled with inspiring young companies that have innovative solutions to address a clean, low-carbon environment and to provide disruptive technologies to make life better
TOMORROW'S WINNERS TODAY
THE ELUSIVE FUSION ENERGY HAS
FINALLY ARRIVED
US Nuclear Corp Invested in MIFTI & MIFTEC: Now Taking Orders for Fusion Energy Futures
In the world of high-risk, high-reward investments, few opportunities can compare to the game-changing potential of nuclear fusion energy. For stock investors, the recent developments surrounding U.S. Nuclear Corp. (UCLE) are positioning the company as a potential breakout star in the energy sector. Five years ago, U.S. Nuclear Corp. made a bold move by investing in two promising fusion energy startups—MIFTI (Magneto Inertial Fusion Technologies, Inc.) and MIFTEC. This move set off a wave of investor excitement, causing U.S. Nuclear’s stock price to surge from a modest $0.25 to a high of $5 per share. And now, with MIFTI's recent groundbreaking announcement of its Early Adopter Program for its revolutionary Staged Z-Pinch Fusion Technology, U.S. Nuclear's stock is poised for another explosive upward movement.
MIFTI's Breakthrough Fusion Technology Is a Game-Changer
The fusion energy landscape has long been filled with promise, but significant technical and financial hurdles have kept true commercial fusion power out of reach—until now. MIFTI’s patented Staged Z-Pinch Fusion Technology has shown the potential to fundamentally alter the way we produce both electricity and radioisotopes. Fusion energy, unlike conventional nuclear energy, relies on the process of combining light atomic nuclei to release vast amounts of energy, without the need for dangerous radioactive materials like uranium. MIFTI’s reactors are small, safe, and capable of producing clean, abundant energy.
As MIFTI takes its first steps toward the construction of the world’s first fusion-based energy and isotope production reactors, U.S. Nuclear Corp.’s investment is poised to yield substantial returns. The company's early involvement in MIFTI has placed it at the forefront of this breakthrough, with the potential for massive growth as MIFTI moves closer to commercializing its fusion reactors.
A few known competing radioisotope companies are ASP Isotopes (ASPI: NASD) Cardinal Health (CAH: NYSE) and Lantheus Holdings (LNTH: NASD). It is important to note that MIFTI/MIFTEC fusion technology produces no long-term radiation which means that MIFTI will be able to substantially undercut the price to gain market share but probably will not have to because of the existing severe shortages.
The Early Adopter Program: Pre-Orders for Energy and Radioisotopes
On January 29, 2025, MIFTI launched its Early Adopter Program, offering a unique opportunity for organizations to secure pre-orders for access to fusion-generated electricity and radioisotopes. This program targets industries that are experiencing significant shortages in energy and medical isotopes—two sectors with immense global demand.
For investors, this is a critical signal. The Early Adopter Program validates MIFTI’s technology and positions it to capture a significant share of the energy and medical markets. Industries dependent on high-energy consumption, such as AI data centers, as well as those relying on radioisotopes for medical research and industrial applications, are facing supply shortages. MIFTI’s fusion reactors, which produce energy and isotopes without the risks associated with traditional fission reactors, offer a solution that can fill these gaps.
Explosive Market Potential in Healthcare and Industrial Sectors
MIFTI’s fusion technology also represents a breakthrough in the production of medical radioisotopes, which are critical for advanced medical imaging and cancer treatments. The vast majority of radioisotopes used in healthcare today are produced through fission reactors, which are aging and at risk of being decommissioned in the coming years. This could lead to a global shortage, creating an urgent need for alternative sources—something MIFTI's fusion reactors are uniquely positioned to address.
In addition, the industrial applications of fusion-generated isotopes are vast. These include non-destructive testing for aircraft parts, quantum computing, and environmental monitoring. The global demand for such isotopes is only expected to grow, providing U.S. Nuclear Corp. with the potential for significant returns as MIFTI’s reactors go into full-scale production.
U.S. Nuclear’s Strategic Positioning for Future Growth
U.S. Nuclear Corp.’s strategic investment in MIFTI and MIFTEC sets the company up to benefit directly from the commercialization of fusion energy. With the fusion industry on the verge of major breakthroughs, investors have a rare opportunity to get in early on a potential industry leader. U.S. Nuclear’s stock has already demonstrated explosive growth in the past, and with MIFTI’s recent progress, the stock is primed for another surge.
MIFTI’s success could mean more than just a strong return on investment for U.S. Nuclear's shareholders. It could also cement the company’s position as a leader in the clean energy space, as fusion energy rapidly moves from theoretical research to practical, real-world applications.
The Road to Net Energy Gain and Profitable Future
One of the most exciting aspects of MIFTI’s technology is its path toward Net Energy Gain—a milestone that has eluded fusion researchers for decades. A leading National Lab published a report predicting that MIFTI has the ability to produce more energy from its reactors than it consumes, today, not in 30 years, positioning the company as a frontrunner in the energy revolution.
For U.S. Nuclear Corp., this success represents an opportunity for long-term growth. As MIFTI achieves milestones in energy production and isotope manufacturing, U.S. Nuclear stands to benefit from its investment in this groundbreaking technology, providing investors with significant upside potential.
Conclusion
With fusion energy on the brink of becoming a reality, U.S. Nuclear Corp. offers an enticing investment opportunity. As the company continues to benefit from its stake in MIFTI and MIFTEC, stockholders are positioned to capitalize on the transformative potential of fusion energy. Investors looking to get ahead of the curve should consider purchasing U.S. Nuclear Corp. shares now—before the fusion energy revolution takes hold and the stock price surges once again.
Legal Disclosures and Disclaimers
Green Planet Microcaps is not a registered investment adviser. The information that we provide from our website or newsletters is not, and should not be construed in any manner, to be investment advice. All opinions and information provided on this site are for educational and research purposes. Green Planet Microcaps encourages all readers to do their own due diligence and research when determining which investment strategies are best suited for them or to seek the advice of an investment professional.
Any information provided by Green Planet Microcaps should not be construed by any subscriber or prospective subscriber as a solicitation by Green Planet Microcaps to effect, or attempt to effect, any transaction in any security. Investments in the securities markets, and especially in private securities of small start-up companies, are incredibly and highly speculative and involve substantial risk that your entire investment could be lost. The information that we provide or that is derived from our website and/or newsletters should not be a substitute for advice from an investment professional. We encourage you to obtain personal advice from your professional investment advisor and to make independent investigations before acting on the information that you obtain from Green Planet Microcaps or derive from our website and/or newsletters. Only you can determine what level of risk is appropriate for you.
Specifically, we advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to purchase or trade in stocks or any securities presented on this website and/or in a particular newsletter. All information provided regarding the companies featured comes from the companies themselves, SEC filings, news releases, private placement memoranda, company websites as well as other sources of publicly available information. The profiles of these highlighted public and private companies are not in any way a solicitation or recommendation to buy, sell, or hold these or any other securities.
Most of the information on our website and/or newsletters or that we otherwise provide is derived directly from information published by the companies on which we report and/or from other sources we believe are reliable, without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. The information may contain discussions of, or provide access to, certain positions and recommendations as of a specific date. Due to various factors, including, but not limited to, changing market conditions, such discussions and positions/recommendations may no longer be reflective of current discussions and positions/recommendations. We do not in any way warrant or guarantee the success of nor endorse any action which you take in reliance on the information that we provide or that is derived from our website.
Investors should not rely solely on the information contained on this website or in any specific newsletter. Rather, investors should use the information contained on this Website and/or in newsletters as a starting point for doing additional independent research on the featured private and public companies. The advertisements within this newsletter are not to be construed as offers to purchase securities in the companies which may be the subject of such advertisements pursuant to federal or state law or the laws of any foreign jurisdiction.
Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects’”, “will,” “anticipates,” “estimates,” “believes,” “understands” or that by statements indicating certain actions “may,” “could,” or “might” occur. There is no guarantee past performance will be indicative of future results. The accuracy or completeness of the information in this newsletter is only as reliable as the sources they were obtained from. Green Planet Microcaps was not compensated for this article and will not be liable for any consequential, incidental, punitive, special, exemplary or indirect damages resulting directly or indirectly from the use of or reliance upon any material provided by Green Planet Microcaps or derived from Green Planet Microcap’s website and/or newsletters. Green Planet Microcaps shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscriber’s inability to use or any delay in accessing Green Planet Microcaps website or any other source of material provided by Green Planet Microcaps including newsletters; (3) any absence of material on Green Planet Microcaps; (4) Green Planet Microcaps failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material. Green Planet Microcaps and each subscriber acknowledge that, without limitation, the above-enumerated conditions cannot be the probable result of any breach of any agreement between Green Planet Microcaps and the subscriber.
Green Planet Microcaps is not affiliated with any brokerage firm and does not endorse or recommend any specific brokerage firm. Green Planet Microcaps is not and will not be responsible for any trades made by a broker on the subscriber’s behalf under any circumstances.